Sage Therapeutics

Youtube Subscribe

Open: 21.75 Close: 21.85 Change: 0.1

The stock market through the eyes of an AI: Sage Therapeutics Company Inc.

The game is changing. There is a new strategy to evaluate Sage Therapeutics fundamental value, possible risks and most salient advantages. Investors have traditionally relied in reading large amounts of text to evaluate the fundamental value of a stock or company. However, the development of Artificial Intelligence (AI) tools is modifying the way investments are evaluated in markets. Today, machine learning, natural language processing and bigdata allow making this process automatic, reducing large amounts of text to the elements that have a higher activation in a neural network. We programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Sage Therapeutics are: Sage, Therapeutics, company, Inc, investor, firm, hedge, …

Concept Map

Semantic Network

Stock Summary

25 out of the 910 hedge funds surveyed by Insider Monkey had bought and owned Sage Therapeutics, Inc. The company has a 52 week low of $22.51 and a high of $59.99. Tower Research Capital.

Today's Summary

25 out of the 910 hedge funds surveyed by Insider Monkey had bought and owned Sage Therapeutics, Inc. The company has a 52 week low of $22.51 and a high of $59.99. Tower Research Capital LLC TRC increased its holdings in Sage Theraputics by 74.0% during the third quarter.

Today's News

Recent study raises questions about safety of Sage Therapeutics Zurzuvae (zuranolone) for postpartum depression, charging that the drug exerts risks similar to those seen with benzodiazepines. 25 out of the 910 hedge funds surveyed by Insider Monkey had bought and owned Sage Therapeutics, Inc. (NASDAQ: SAGE) As of September 2023, 25 of the 10,000 hedge fund investors surveyed had bought the company. The company has a 52 week low of $22.51 and a high of $59.99. Sage Therapeutics, Inc, a biopharmaceutical company, develops and commercializes brain health medicines. Tower Research Capital LLC TRC increased its holdings in Sage Theraputics by 74.0% during the third quarter. Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. The firm encourages investors to contact the firm. The firm is investigating potential claims against Sage Theraputics. Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. Company size 501-1,000 employees is expected to be around 690.

Stock Profile

" Recent study raises questions about safety of Sage Therapeutics Zurzuvae (zuranolone) for postpartum depression, charging that the drug exerts risks similar to those seen with benzodiazepines. 25 out of the 910 hedge funds surveyed by Insider Monkey had bought and owned Sage Therapeutics, Inc. (NASDAQ: SAGE) As of September 2023, 25 of the 10,000 hedge fund investors surveyed had bought the company. The company has a 52 week low of $22.51 and a high of $59.99. Sage Therapeutics, Inc, a biopharmaceutical company, develops and commercializes brain health medicines. Tower Research Capital LLC TRC increased its holdings in Sage Theraputics by 74.0% during the third quarter. Pomerantz LLP is investigating claims on behalf of investors of Sage Therapeutics, Inc. The firm encourages investors to contact the firm. The firm is investigating potential claims against Sage Theraputics. Sage Therapeutics is a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with debilitating disorders of the brain. Company size 501-1,000 employees is expected to be around 690."

Keywords

Are looking for the most relevant information about Sage Therapeutics? Investor spend a lot of time searching for information to make investment decisions in Sage Therapeutics. This task is often burdensome and consumes huge amounts of free time. It also leads to mistakes due to fatigue and bounded rationality. As a solution, we programmed an artificial intelligence that reads the whole internet and the uses natural language processing and vectorizers to summarize the information. Usually, the AI reads several hundred pages and summarize it to a short document. This document presents our results. We found that the most common words in the internet about Sage Therapeutics are: Sage, Therapeutics, company, Inc, investor, firm, hedge, and the most common words in the summary are: sage, therapeutic, job, stock, company, report, inc, . One of the sentences in the summary was: Tower Research Capital LLC TRC increased its holdings in Sage Theraputics by 74.0% during the third quarter.. Other searches related to this term that the AI found were: stockmarketlive, livestock, stockmarketforbeginners, thestockmarket, stockmarkettoday, stockmarkettrading, stockmarketstocks, todaystockmarket, thestockmarket, marketnews, stockmarketnews, whatisstockmarket, usstockmarket, stockmarketopen. #sage #therapeutic #job #stock #company #report #inc.

Read more →

Youtube Subscribe

---